BioMarin Pharmaceutical
BMRN
#1888
Rank
โ‚น1.018 T
Marketcap
โ‚น5,257
Share price
-0.16%
Change (1 day)
12.62%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): โ‚น64.16

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is โ‚น35.66. In 2022 the company made an earnings per share (EPS) of โ‚น72.13 an increase over its 2021 EPS that were of -โ‚น32.84.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น64.16-11.05%
2022โ‚น72.13-319.62%
2021-โ‚น32.84-107.38%
2020โ‚น444.77-3485.71%
2019-โ‚น13.14-67.44%
2018-โ‚น40.35-34.85%
2017-โ‚น61.93-83.21%
2016-โ‚น368.76263.89%
2015-โ‚น101.3418.68%
2014-โ‚น85.39-28.91%
2013-โ‚น120.1134.74%
2012-โ‚น89.1493.88%
2011-โ‚น45.98-124.5%
2010โ‚น187.66
2009N/A-100%
2008โ‚น30.03-300%
2007-โ‚น15.01-54.29%
2006-โ‚น32.84-67.89%
2005-โ‚น102.28-62.54%
2004-โ‚น273.05136.59%
2003-โ‚น115.41-15.17%
2002-โ‚น136.06-11.59%
2001-โ‚น153.8956.19%
2000-โ‚น98.5210.53%
1999-โ‚น89.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น178.56 400.77%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น547.98-1,636.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น35.66-200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น1.88-105.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.32-128.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น169.84 376.32%๐Ÿ‡บ๐Ÿ‡ธ USA